# Delaware Institute for Reproductive Medicine, P.A – FDA Inspection, Jun 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/637058bc-c8e1-4b70-9344-456c2eccbe8a
Source feed: FDA_Inspections

> FDA inspection 1094217 of Delaware Institute for Reproductive Medicine, P.A, June 20, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094217
- Company Name: Delaware Institute for Reproductive Medicine, P.A
- Inspection Date: 2019-06-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1293390 - 2025-09-16
- FDA Inspection 1187482 - 2022-10-26
- FDA Inspection 1018967 - 2017-06-08
- FDA Inspection 925928 - 2015-05-13
- FDA Inspection 831892 - 2013-05-16

## Related Officers

- [Company Rep](https://www.keypedia.com/people/erika-m-wilkerson/cd1c299d-c827-4d52-8e2b-719989da9991)

Company: https://www.keypedia.com/companies/delaware-institute-for-reproductive-medicine-pa/15cecf6a-a321-4390-9048-921999542784

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d